1 hour agoPolitics
34LENS
4 SourcesUnited States
thebalanced.newsTrump Signs Executive Order to Accelerate Psychedelic Drug Research Including Ibogaine
President Donald Trump signed an executive order directing the FDA to expedite research and clinical trials on psychedelic drugs like ibogaine, aiming to improve treatments for PTSD and mental health issues, especially among veterans. The order includes a $50 million federal investment to support state-level research and facilitates access under the Right to Try law for critically ill patients. The announcement, made with health officials and podcaster Joe Rogan present, also seeks to reduce regulatory barriers and encourage drug rescheduling if approved.
Political Bias
20%71%9%
Sentiment
66%
AI Analysis
Political bias across 4 sources
● Left 20%● Center 71%● Right 9%
The articles present perspectives from the Trump administration emphasizing support for veterans and medical research, highlighting bipartisan elements such as Joe Rogan's presence and comments. Coverage includes official statements and advocacy voices without partisan critique, focusing on policy actions and potential benefits. Some sources note Trump’s personal remarks and Rogan’s political views, reflecting a mix of political and cultural angles without overt bias.
Sentiment — Positive (66/100)
The overall tone is cautiously optimistic, emphasizing potential medical benefits and regulatory progress. Coverage highlights hopeful aspects for veterans and patients while acknowledging the experimental nature of the treatments. Some articles include lighthearted or critical remarks from Joe Rogan, adding a nuanced, less formal tone. There is no strong negative sentiment; rather, the sentiment balances enthusiasm for innovation with recognition of ongoing challenges.
How 4 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| hindustantimes | Trump vs Joe Rogan reaches the White House; quips 'I'd like some Ibogaine' after signing new order | Center | Neutral |
| hindustantimes | What is ibogaine? Trump signs order to fast track psychedelic drug research, here's why | Center | Positive |
| wion | Trump signs executive order to fast-track psychedelic drug research, announces 50 million support | Center | Positive |
| moneycontrol | Trump signs order easing restrictions on psychedelic drugs- Moneycontrol.com | Center | Positive |
Coverage timeline
moneycontrol broke this story on 18 Apr, 02:17 pm. Other outlets followed.
- 1moneycontrol18 Apr, 02:17 pmTrump signs order easing restrictions on psychedelic drugs- Moneycontrol.com
- 2wion18 Apr, 02:40 pmTrump signs executive order to fast-track psychedelic drug research, announces 50 million support
- 3hindustantimes18 Apr, 02:58 pmWhat is ibogaine? Trump signs order to fast track psychedelic drug research, here's why
- 4hindustantimes18 Apr, 03:14 pmTrump vs Joe Rogan reaches the White House; quips 'I'd like some Ibogaine' after signing new order
Lens Score breakdown
34/100
Public interest0/100
Coverage gap90%
Well-covered story — coverage matches public importance.
Who's involved
Institutions and figures named across source coverage.
Government
Department of Veterans AffairsUS Federal GovernmentFood and Drug AdministrationWhite HouseHealth and Human ServicesUS Food and Drug Administration
Political
President Donald TrumpBiden AdministrationFederal Health OfficialsDonald TrumpUS President
Story context
- Category
- Politics
- Location
- United States
- Sources analysed
- 4
- Last analysed
- 18 Apr 2026
- Key entities
- Post-traumatic stress disorderDonald TrumpFood and Drug AdministrationIbogaineExecutive order (United States)Psychedelic drugClinical trialUnited StatesHallucinogenMDMATabernanthe ibogaPsychoactive drug
Related Coverage
Select a news story to see related coverage from other media outlets.